"Executive Summary Dapagliflozin Market: Share, Size & Strategic Insights The global dapagliflozin market is driven by the increasing prevalence of diabetes, heart failure, and chronic kidney disease (CKD). According to the International Diabetes Federation (IDF), approximately 537 million adults aged 20-79 were living with diabetes in 2021, with the number expected to rise to 643...